You have no items in your shopping cart.
On Promotion 
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'IL-12'
Human IL-23 [orb2993911]Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 90% as determined by SEC-HPLC. (QC verified)
Predicted: 19.7&34.8 KDa. Observed: 19-21&40-60 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg- Human IL-23 [orb2993914]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 81.3 KDa. Observed: 80-110 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human IL-23 [orb2994028]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 55.2 KDa. Observed: 60-90 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Mouse IL-23 [orb2994202]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 90% as determined by SEC-HPLC. (QC verified)
Predicted: 19.7&35.8 KDa. Observed: 18&40-55 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human IL-23A & mouse IL-12B Heterodimer [orb2993931]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 56.9 KDa. Observed: 65-80 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Mouse IL-12B [orb2994366]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 36.8 KDa. Observed: 42-55 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Mouse IL-12RB2 [orb2994394]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 98.4 KDa. Observed: 125-160 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Mouse IL-23 [orb2994552]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 19.7&36.8 KDa. Observed: 40-55&20 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human IL-12RB1 [orb2994431]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 84.2 KDa. Observed: 95-110 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human IL-12RB1 [orb2994439]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 58.1 KDa. Observed: 80-110 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg